White Sox reportedly acquiring RHP Huascar Brazobán from Mets for two minor leaguers

The Chicago White Sox are reportedly acquiring right-handed reliever Huascar Brazobán from the New York Mets in exchange for a pair of minor-league arms, per Ken Rosenthal of The Athletic. Sources told Rosenthal that the return heading to New York would be right-hander Gabe Davis and right-hander Zach Franklin.

What happened

Per Rosenthal's reporting for The Athletic, Chicago is set to receive Brazobán — a right-handed reliever — from the Mets, with Davis and Franklin going the other direction. The deal involves two pitchers from different levels of the White Sox system: Davis from the Class AA affiliate and Franklin from the Class AAA affiliate. No additional terms were included in the report, and neither club has issued a statement describing this as a completed transaction.

Why it matters

Bullpen construction at the trade deadline is one of baseball's more reliable rituals — teams with genuine October aspirations tend to treat late-inning relief depth the way the rest of us treat umbrella ownership: you only regret not having it when it's already raining. The White Sox, sitting at 84-78 and one game back in the AL Central, are not a club that can afford to treat the next month as a dress rehearsal.

The reported move would add a right-handed arm to a bullpen that will be asked to protect leads through a stretch run. Per the verified record, Chicago has been eliminated from the division race, which means the path forward runs through the wild card — a format that rewards depth and punishes thin late-inning options in equal measure. Adding a reliever with major-league experience, even at the cost of two minor-league pitchers, reflects the kind of calculus a club makes when it believes the present roster is worth reinforcing.

The cost side of the ledger is worth noting. Davis and Franklin represent organizational depth at the upper levels of the system — arms close enough to the majors to carry real value, but not so close that their departure creates an immediate hole on the active roster. Trading from that tier is a fairly standard price of admission for a proven big-league reliever, and Rosenthal's report frames this as a straightforward exchange rather than a blockbuster.

Where the club stands

### Is Chicago still in contention?

Yes — and meaningfully so. The White Sox enter this reported move at 84-78 (.519), sitting second in the AL Central, one game back of the division lead, and riding a one-game winning streak. They have been eliminated from the division race itself, but at one game back with the calendar still reading early August, the wild card remains very much in play.

The schedule ahead offers no soft landing. Chicago travels to Fenway Park for three games against the Boston Red Sox beginning Tuesday, August 4, with Davis Martin projected to face Patrick Sandoval in the opener. Wednesday brings Sean Burke against Sonny Gray, and Thursday closes the series with Luis Castillo opposing Ranger Suarez. That is not a rotation matchup that invites complacency, and it is precisely the kind of series where a reliable late-inning arm earns his keep — or, in this case, his reported acquisition cost.

Fenway in August, with a wild-card race still breathing down your neck, is not the moment to be sorting out bullpen questions. If this deal closes as reported, Brazobán could be available to contribute during that stretch, though roster mechanics — 40-man placement, any necessary corresponding moves — would need to fall into place first. The report does not address those details.

What we don't know yet

Rosenthal's report, sourced to The Athletic, describes the deal as in progress — not a completed transaction, not a club announcement. Several details remain unaddressed in the reporting.

It is not yet clear whether Brazobán will require a 40-man roster spot, and if so, which corresponding move the White Sox would make to accommodate him. Under general roster rules, a player must be on the 40-man roster to be called up to the active roster, and the 26-man active limit applies through August 31. None of that has been reported as resolved.

The report also does not specify a timeline for when the deal would be finalized, whether any physical examinations are pending, or whether either club has issued a statement. Until one of those things happens, this remains a report of an expected transaction rather than a completed one.

The minor-league profiles of Davis and Franklin — their statistics, organizational rankings, or long-term ceilings — are not included in the reporting, so the full weight of what Chicago is giving up is not yet publicly detailed beyond their levels and handedness.

What to watch

The most immediate question is whether the transaction is formally announced before Tuesday's series opener in Boston. If Brazobán is added to the active roster in time for that series, his role in the bullpen hierarchy — setup, middle relief, high-leverage situations — will become clearer quickly, though the report does not characterize his expected usage.

Watch also for any corresponding 40-man or active roster moves the White Sox announce alongside the deal. Those secondary transactions often tell you as much about a club's roster thinking as the headline acquisition itself. A team that adds a reliever and quietly shuffles two other pieces in the same afternoon is usually telling you something about how it views the next six weeks.

More broadly, this reported move is worth tracking in the context of where Chicago believes it stands. An 84-78 record, one game back, with a three-game road series against Boston on deck — that is a club that has decided it is playing for something real. Whether Brazobán, per Rosenthal's reporting, becomes a meaningful piece of that push is a question the next several weeks will answer.

Neither the White Sox nor the Mets have commented publicly on the reported deal. Per Ken Rosenthal of The Athletic, sources indicate the acquisition is expected to go through.